SCHEMBL3806732

SCHEMBL3806732

COc1ccc(OC)c(P(=O)(CCP(=O)(Sc2ccccc2)c2cc(OC)ccc2OC)Sc2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ ALDH1A1 P00352 5/20 0.39
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ KCNH2 Q12809 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PTK2B Q14289 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA7 P43166 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ HSD11B1 P28845 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3805334 0.83 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL3806737 0.77 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL3787871 0.75 KMT2A (0.52) SMN1; SMN2ALDH1A1MAPTHSD17B10MAPK1
SCHEMBL28659850 0.75 NPC1 (0.44) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL258526 0.73 KMT2A (0.48) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL258833 0.73 KMT2A (0.48) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL6130221 0.73 KMT2A (0.62) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL258525 0.73 KMT2A (0.48) SMN1; SMN2NPC1RAB9AALDH1A1MAPT
SCHEMBL3806734 0.70 CA12 (0.42) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL28673914 0.69 KMT2A (0.47) SMN1; SMN2NPC1RAB9AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010004278-A1 METHOD FOR INCREASING THE ENANTIOMERIC EXCESS OF CHIRAL PHOSPHINE OXIDES, SULPHIDES, IMIDES AND BORANES CELTIC CATALYSTS LIMITED (IE) 2010-01-14 — — WO claimed
WO-2010004278-A1 METHOD FOR INCREASING THE ENANTIOMERIC EXCESS OF CHIRAL PHOSPHINE OXIDES, SULPHIDES, IMIDES AND BORANES CELTIC CATALYSTS LIMITED (IE) 2010-01-14 — — WO disclosed
Send feedback